APA (7th ed.) Citation

Scimeca, M., Montanaro, M., Bonfiglio, R., Anemona, L., Agrò, E. F., Asimakopoulos, A. D., . . . Mauriello, A. (2022). The ETS Homologous Factor (EHF) Represents a Useful Immunohistochemical Marker for Predicting Prostate Cancer Metastasis. Diagnostics (2075-4418), 12(4), 800. https://doi.org/10.3390/diagnostics12040800

Chicago Style (17th ed.) Citation

Scimeca, Manuel, et al. "The ETS Homologous Factor (EHF) Represents a Useful Immunohistochemical Marker for Predicting Prostate Cancer Metastasis." Diagnostics (2075-4418) 12, no. 4 (2022): 800. https://doi.org/10.3390/diagnostics12040800.

MLA (9th ed.) Citation

Scimeca, Manuel, et al. "The ETS Homologous Factor (EHF) Represents a Useful Immunohistochemical Marker for Predicting Prostate Cancer Metastasis." Diagnostics (2075-4418), vol. 12, no. 4, 2022, p. 800, https://doi.org/10.3390/diagnostics12040800.